Skip to content

Clinical trials

Scleroderma, Systemic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: France Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20072
20091
20102
20112
20128
201310
20146
20156
20164
20174
201811
20194
20208
202113
202210
202311
20246
20255
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Recruiting28
Unknown status16
Not yet recruiting8
Terminated5
Active, not recruiting4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris17
University Hospital, Lille12
Assistance Publique Hopitaux De Marseille7
University Hospital, Bordeaux7
University Hospital, Strasbourg, France7
University Hospital, Grenoble6
Central Hospital, Nancy, France5
University Hospital, Montpellier5
Boehringer Ingelheim4
Poitiers University Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic128
Scleroderma, Diffuse19
Lupus Erythematosus, Systemic14
Autoimmune Diseases11
Lung Diseases, Interstitial10
Arthritis, Rheumatoid9
Myositis9
Sjogren's Syndrome6
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis4
Connective Tissue Diseases4

Trials

Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.